Acute promyelocytic leukemia: A case-based review

Hematology

Volumn 8, Issue 2, 2003, Pages 105-113

  Gupta, Vikas ^a   Tabak, Daniel ^b   Keating, Armand ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Instituto de Cancer   (Brazil)

Author keywords

Acute promyelocytic leukemia; Maintenance therapy; Prognosis; Relapsed APL

Indexed keywords

ANTHRACYCLINE; ANTIBIOTIC AGENT; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; DEXAMETHASONE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CANCER RECURRENCE; CANCER RESEARCH; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FATALITY; FEVER; HEADACHE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOPHENOTYPING; LIVER TOXICITY; LONG QT SYNDROME; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; MALE; MEDICAL DECISION MAKING; NEUROTOXICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; RETINOIC ACID SYNDROME; RETROSPECTIVE STUDY; REVIEW; TORSADE DES POINTES;

EID: 0346448021     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/1024533031000090801     Document Type: Review

References (79)

1. De Rossi, G., Avvisati, G., Coluzzi, S., Fenu, S., LoCoco, F., Lopez, M., Nanni, M., Pasqualetti, D. and Mandelli, F. (1990) "Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases", Eur. J. Haematol. 45, 168-171.
2. Paietta, E., Andersen, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P., Rowe, J. and Wiernik, P.H. (1994) "The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study", Leukemia 8, 1108-1112.
3. Orfao, A., Chillon, M.C., Bortoluci, A.M., Lopez-Berges, M.C., Garcia-Sanz, R., Gonzalez, M., Tabernero, M.D., Garcia-Marcos, M.A., Rasillo, A.I., Hernandez-Rivas, J. and San Miguel, J.F. (1999) "The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements", Haematologica 84, 405-412.
4. Larson, R.A., Kondo, K., Vardiman, J.W., Butler, A.E., Golomb, H.M. and Rowley, J.D. (1984) "Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia", Am. J. Med. 76, 827-841.
5. de The, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990) "The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus", Nature 347, 558-561.
6. Kakizuka, A., Miller, Jr., W.H., Umesono, K., Warrell, R.P., Jr, Frankel, S.R., Murty, V.V., Dmitrovsky, E. and Evans, R.M. (1991) "Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML", Cell 66, 663-674.
7. Chen, S.J., Zelent, A., Tong, J.H., Yu, H.Q., Wang, Z.Y., Derre, J., Berger, R., Waxman, S. and Chen, Z. (1993) "Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia", J. Clin. Investig. 91, 2260-2267.
8. Chen, Z., Brand, N.J., Chen, A., Chen, S.J., Tong, J.H., Wang, Z.Y., Waxman, S. and Zelent, A. (1993) "Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia", EMBO J. 12, 1161-1167.
9. Redner, R.L., Rush, E.A., Faas, S., Rudert, W.A. and Corey, S.J. (1996) "The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion", Blood 87, 882-886.
10. Arnould, C., Philippe, C., Bourdon, V., Gr goire, M.J., Berger, R. and Jonveaux, P. (1999) "The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia", Hum. Mol. Genet. 8, 1741-1749.
11. Licht, J.D., Chomienne, C., Goy, A., Chen, A., Scott, A.A., Head, D.R., Michaux, J.L., Wu, Y., DeBlasio, A., Miller, W.H., Jr, et al. (1995) "Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)", Blood 85, 1083-1094.
12. Grimwade, D., Biondi, A., Mozziconacci, M.J., Hagemeijer, A., Berger, R., Neat, M., Howe, K., Dastugue, N., Jansen, J., Radford-Weiss, I, Lo Coco, F., Lessard, M., Hernandez, J.M., Delabesse, E., Head, D., Liso, V., Sainty, D., Flandrin, G., Solomon, E., Birg, F. and Lafage-Pochitaloff, M. (2000) "Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK, Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action Molecular Cytogenetic Diagnosis in Haematological Malignancies", Blood 96, 1297-1308.
13. Dombret, H., Scrobohaci, M.L., Ghorra, P., Zini, J.M., Daniel, M.T., Castaigne, S. and Degos, L. (1993) "Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment", Leukemia 7, 2-9.
14. Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne' C., Link, H., Guerci, A., Duarte, M., Daniel, M.T., Bowen, D., et al. (1993) "Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group", Blood 82, 3241-3249.
15. Falanga, A., Iacoviello, L., Evangelista, V., Belotti, D., Consonni, R., D'Orazio, A., Robba, L., Donati, M.B. and Barbui, T. (1995) "Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid", Blood 86, 1072-1081.
16. Fenaux, P, Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. and Degos, L. (1999) "A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group", Blood 94, 1192-1200.
17. Di Bona, E., Avvisati, G., Castaman, G., Luce Vegna, M., De Sanctis, V., Rodeghiero, F. and Mandelli, F. (2000) "Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia", Br. J. Haematol. 108, 689-695.
18. Head, D., Kopecky, K.J., Weick, J., Files, J.C., Ryan, D., Foucar, K., Montiel, M., Bickers, J., Fishleder, A., Miller, M., et al. (1995) "Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia", Blood 86, 1717-1728.
19. Marty, M., Ganem, G., Fischer, J., Flandrin, G., Berger, R., Schaison, G., Degos, L. and Boiron, M. (1984) "[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]", Nouv. Rev. Fr. Hematol. 26, 371-378.
20. Petti, M.C., Avvisati, G., Amadori, S., Baccarani, M., Guarini, A.R., Papa, G., Rosti, G.A., Tura, S. and Mandelli, F. (1987) "Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients", Haematologica 72, 151-155.
21. Avvisati, G., Mandelli, F., Petti, M.C., Vegna, M.L., Spadea, A., Liso, V., Specchia, G., Bernasconi, C., Alessandrino, E.P., Piatti, C., et al. (1990) "Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA", Eur. J. Haematol. 44, 257-260.
22. Estey, E., Thall, P.F., Pierce, S., Kantarjian, H. and Keating, M. (1997) "Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine", J. Clin. Oncol. 15, 483-490.
23. Avvisati, G., Petti, M.C., Lo-Coco, F., Vegna, M.L., Amadori, S., Baccarani, M., Cantore, N., Di Bona, E., Ferrara, F., Fioritoni, G., Gallo, E., Invernizzi, R., Lazzarino, M., Liso, V., Mariani, G., Ricciuti, F., Selleri, C., Sica, S., Veneri, D. and Mandelli, F. (2002) "Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up", Blood 100, 3141-3146.
24. Paietta, E., Andersen, J., Racevskis, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P. and Wiernik, P.H. (1994) "Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses", Leukemia 8, 968-973.
25. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. and Wiernik, P.H. (1997) "All-trans-retinoic acid in acute promyelocytic leukemia", N. Engl. J. Med. 337, 1021-1028.
26. Sanz, M.A., Martin, G., Rayon, C., Esteve, J., Gonzalez, M., Diaz-Mediavilla, J., Bolufer, P., Barragan, E., Terol, M.J., Gonzalez, J.D., Colomer, D., Chillon, C., Rivas, C., Gomez, T., Ribera, J.M., Bornstein, R., Roman, J., Calasanz, M.J., Arias, J., Alvarez, C., Ramos, F. and Deben, G. (1999) "A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group", Blood 94, 3015-3021.
27. Fenaux, P., Castaigne, S., Chomienne, C., Dombret, H. and Degos, L. (1992) "All trans retinoic acid treatment for patients with acute promyelocytic leukemia", Leukemia 6(Suppl 1), 64-66.
28. Frankel, S.R., Eardley, A., Lauwers, G., Weiss, M. and Warrell, Jr., R.P. (1992) "The "retinoic acid syndrome" in acute promyelocytic leukemia", Ann. Intern. Med. 117, 292-296.
29. De Botton, S., Dombret, H., Sanz, M., Miguel, J.S., Caillot, D., Zittoun, R., Gardembas, M., Stamatoulas, A., Conde, E., Guerci, A., Gardin, C., Geiser, K., Makhoul, D.C., Reman, O., de la. Serna, J., Lefrere, F., Chomienne, C., Chastang, C., Degos, L. and Fenaux, P. (1998) "Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group", Blood 92, 2712-2718.
30. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Rowe, J.M., Francois, C., Larson, R.S. and Wiernik, P.H. (2000) "Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome", Blood 95, 90-95.
31. Warrell, Jr., R.P., Maslak, P., Eardley, A., Heller, G., Miller, W.H., Jr and Frankel, S.R. (1994) "Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience", Leukemia 8, 929-933.
32. Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, N. and Ohno, R. (1998) "Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group", J. Clin. Oncol. 16, 78-85.
33. Dubois, C., Schlageter, M.H., de Gentile, A., Balitrand, N., Toubert, M.E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y., Degos, L., et al. (1994) "Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia", Leukemia 8, 1750-1757.
34. Larson, R.S., Brown, D.C. and Sklar, L.A. (1997) "Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2", Blood 90, 2747-2756.
35. Vahdat, L., Maslak, P., Miller, Jr., W.H., Eardley, A., Heller, G., Scheinberg, D.A. and Warrell, R.P., Jr. (1994) "Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid", Blood 84, 3843-3849.
36. Ko, B.S., Tang, J.L., Chen, Y.C., Yao, M., Wang, C.H., Shen, M.C. and Tien, H.F. (1999) "Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia-the occurrence of retinoic acid syndrome is a risk factor", Leukemia 13, 1406-1408.
37. Specchia, G., Lo Coco, F., Vignetti, M., Avvisati, G., Fazi, P., Albano, F., Di Raimondo, F., Martino, B., Ferrara, F., Selleri, C., Liso, V. and Mandelli, F. (2001) "Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto", J. Clin. Oncol. 19, 4023-4028.
38. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., Brunning, R., Gale, R.P., Grever, M.R., Keating, M.J., et al. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. Oncol. 8, 813-819.
39. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. and Lo Coco, F. (1997) "Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups", Blood 90, 1014-1021.
40. Burnett, A.K., Grimwade, D., Solomon, E., Wheatley, K. and Goldstone, A.H. (1999) "Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial", Blood 93, 4131-4143.
41. Kantarjian, H.M., Keating, M.J., Walters, R.S., Smith, T.L., McCredie, K.B. and Freireich, E.J. (1987) "Role of maintenance chemotherapy in acute promyelocytic leukemia", Cancer 59, 1258-1263.
42. Chou, W.C., Tang, J.L., Yao, M., Liang, Y.J., Lee, F.Y., Lin, M.T., Wang, C.H., Shen, M.C., Chen, Y.C. and Tien, H.F. (1997) "Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment", Leukemia 11, 921-928.
43. Sanz, M.A., Lo Coco, F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzalez, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. and Mandelli, F. (2000) "Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups", Blood 96, 1247-1253.
44. Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., Boccuni, P., Di Noto, R., Pane, F., Annunziata, M., Schiavone, E.M., De Simone, M., Guglielmi, C., Del Vecchio, L. and Lo Coco, F. (2000) "CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy", J. Clin. Oncol. 18, 1295-1300.
45. Murray, C.K., Estey, E., Paietta, E., Howard, R.S., Edenfield, W.J., Pierce, S., Mann, K.P., Bolan, C. and Byrd, J.C. (1999) "CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?", J. Clin. Oncol. 17, 293-297.
46. Schoch, C., Haase, D., Haferlach, T., Freund, M., Link, H., Lengfelder, E., Loffler, H., Buchner, T. and Fonatsch, C. (1996) "Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients", Br. J. Haematol. 94, 493-500.
47. Slack, J.L., Arthur, D.C., Lawrence, D., Mrozek, K., Mayer, R.J., Davey, F.R., Tantravahi, R., Pettenati, M.J., Bigner S., Carroll, A.J., Rao, K.W., Schiffer, C.A. and Bloomfield, C.D. (1997) "Secondary cytogenetic changes in acute promyelocytic leukemia-prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study", J. Clin. Oncol. 15, 1786-1795.
48. Hiorns, L.R., Swansbury, G.J., Mehta, J., Min, T., Dainton, M.G., Treleaven, J., Powles, R.L. and Catovsky, D. (1997) "Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia", Br. J. Haematol. 96, 314-321.
49. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. and Goldstone, A. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties", Blood 92, 2322-2333.
50. Grimwade, D. (2001) "The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia", Best Pract. Res. Clin. Haematol. 14, 497-529.
51. Huang, W., Sun, G.L., Li, X.S., Cao, Q., Lu, Y., Jang, G.S., Zhang, F.Q., Chai, J.R., Wang, Z.Y., Waxman, S., et al. (1993) "Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse", Blood 82, 1264-1269.
52. Jurcic, J.G., Nimer, S.D., Scheinberg, D.A., DeBlasio, T., Warrell, Jr., R.P. and Miller, W.H., Jr (2001) "Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia", Blood 98, 2651-2656.
53. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Miyawaki, S., Shimazaki, C., Miyake, T., Nakayama, Y., Kobayashi, H., Goto, S., et al. (1995) "Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)", Leukemia 9, 1478-1482.
54. Gallagher, R.E., Willman, C.L., Slack, J.L., Andersen, J.W., Li, Y.P., Viswanatha, D., Bloomfield, C.D., Appelbaum, F.R., Schiffer, C.A., Tallman, M.S. and Wiernik, P.H. (1997) "Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study", Blood 90, 1656-1663.
55. Slack, J.L., Willman, C.L., Andersen, J.W., Li, Y.P., Viswanatha, D.S., Bloomfield, C.D., Tallman, M.S. and Gallagher, R.E. (2000) "Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129", Blood 95, 398-403.
56. Lo Coco, F., Diverio, D., Pandolfi, P.P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M.C., Meloni, G., et al. (1992) "Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia", Lancet 340, 1437-1438.
57. Diverio, D., Rossi, V., Avvisati, G., De Santis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M.C., Santoro, A., Pelicci, P.G., Mandelli, F., Biondi, A. and Lo Coco, F. (1998) "Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter 'AIDA' trial. GIMEMA-AIEOP Multicenter 'AIDA' Trial", Blood 92, 784-789.
58. Detourmignies, L., Castaigne, S., Stoppa, A.M., Harousseau, J.L., Sadoun, A., Janvier, M., Demory, J.L., Sanz, M., Berger, R., Bauters, F., et al. (1992) "Therapy-related acute promyelocytic leukemia: a report on 16 cases", J. Clin. Oncol. 10, 1430-1435.
59. Pollicardo, N., O'Brien, S., Estey, E.H., al-Bitar, M., Pierce, S., Keating, M. and Kantarjian, H.M. (1996) "Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution", Leukemia 10, 27-31.
60. Gillis, S., Sofer, O., Zelig, O., Dann, E.J., Lotan, H., Ben Yehuda, D., Isacson, R., Rachmilewitz, E.A., Ben-Bassat, I. and Polliack, A. (1995) "Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease-a report of 4 cases", Ann. Oncol. 6, 777-779.
61. Pulsoni, A., Pagano, L., Lo Coco, F., Avvisati, G., Mele, L., Di Bona, E., Invernizzi, R., Leoni, F., Marmont, F., Mele, A., Melillo, L., Nosari, A.M., Pogliani, E.M., Vignetti, M., Visani, G., Zagonel, V., Leone, G. and Mandelli, F. (2002) "Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. PG-1972-6", Blood, 100.
62. Gallagher, R.E. (2002) "Retinoic acid resistance in acute promyelocytic leukemia", Leukemia 16, 1940-1958.
63. Jurcic, J.G., DeBlasio, T., Dumont, L., Yao, T.J. and Scheinberg, D.A. (2000) "Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia", Clin. Cancer Res. 6, 372-380.
64. Estey, E.H., Giles, F.J., Beran, M., O'Brien, S., Pierce, S.A., Faderl, S.H., Cortes, J.E. and Kantarjian, H.M. (2002) "Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia", Blood 99, 4222-4224.
65. Petti, M.C., Pinazzi, M.B., Diverio, D., Romano, A., Petrucci, M.T., De Santis, S., Meloni, G., Tafuri, A., Mandelli, F. and Lo Coco, F. (2001) "Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)", Br. J. Haematol. 115, 63-65.
66. Niu, C., Yan, H., Yu, T., Sun, H.P., Liu, J.X., Li, X.S., Wu, W., Zhang, F.Q., Chen, Y., Zhou, L., Li, J.M., Zeng, X.Y., Yang, R.R., Yuan, M.M., Ren, M.Y., Gu, F.Y., Cao, Q., Gu, B.W., Su, X.Y., Chen, G.Q., Xiong, S.M., Zhang, T., Waxman, S., Wang, Z.Y., Chen, S.J., et al. (1999) "Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients", Blood 94, 3315-3324.
67. Soignet, S.L., Frankel, S.R., Douer, D., Tallman, M.S., Kantarjian, H., Calleja, E., Stone, R.M., Kalaycio, M., Scheinberg, D.A., Steinherz, P., Sievers, E.L., Coutre, S., Dahlberg, S., Ellison, R. and Warrell, R.P., Jr (2001) "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia", J. Clin. Oncol. 19, 3852-3860.
68. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins", Blood 88, 1052-1061.
69. 3 exerts dose-dependent dual effects on APL cells", Blood 89, 3345-3353.
70. Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., Sugiyama, S., Satoh, H., Terada, H. and Ohno, R. (2000) "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia", Ann. Intern, Med. 133, 881-885.
71. Unnikrishnan, D., Dutcher, J.P., Varshneya, N., Lucariello, R., Api, M., Garl, S., Wiernik, P.H. and Chiaramida, S. (2001) "Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide", Blood 97, 1514-1516.
72. Westervelt, P., Brown, R.A., Adkins, D.R., Khoury, H., Curtin, P., Hurd, D., Luger, S.M., Ma, M.K., Ley, T.J. and DiPersio, J.F. (2001) "Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide", Blood 98, 266-271.
73. Camacho, L.H., Soignet, S.L., Chanel, S., Ho, R., Heller, G., Scheinberg, D.A., Ellison, R. and Warrell, R.P., Jr. (2000) "Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide", J. Clin. Oncol. 18, 2620-2625.
74. Lu, D.P., Qiu, J.Y., Jiang, B., Wang, Q., Liu, K.Y., Liu, Y.R. and Chen, S.S. (2002) "Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. PG-3136-43", Blood 99.
75. Nabhan, C., Mehta, J. and Tallman, M.S. (2001) "The role of bone marrow transplantation in acute promyelocytic leukemia", Bone Marrow Transplant. 28, 219-226.
76. Meloni, G., Diverio, D., Vignetti, M., Avvisati, G., Capria, S., Petti, M.C., Mandelli, F. and Lo Coco, F. (1997) "Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual. disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene", Blood 90, 1321-1325.
77. Thomas, X., Dombret, H., Cordonnier, C., Pigneux, A., Gardin, C., Guerci, A., Vekhoff, A., Sadoun, A., Stamatoullas, A., Fegueux, N., Maloisel, F., Cahn, J.Y., Reman, O., Gratecos, N., Berthou, C., Huguet, F., Kotoucek, P., Travade, P., Buzyn, A., de Revel, T., Vilque, J.P., Naccache, P., Chomienne, C., Degos, L. and Fenaux, P. (2000) "Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia", Leukemia 14, 1006-1013.
78. Zompi, S., Legrand, O., Bouscary, D., Blanc, C.M., Picard, F., Casadevall, N., Dreyfus, F., Marie, J.P. and Viguie, F. (2000) "Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature", Br. J. Haematol. 110, 610-613.
79. Latagliata, R., Petti, M.C., Fenu, S., Mancini, M., Spiriti, M.A., Breccia, M., Brunetti, G.A., Avvisati, G., Lo Coco, F. and Mandelli, F. (2002) "Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem", Blood 99, 822-824.